Matrix metalloproteinases: Implication in vascular matrix remodelling during atherogenesis

Clinical Science

Volumn 94, Issue 2, 1998, Pages 103-110

  Ye, Shu ^a   Humphries, Steve ^b   Henney, Adriano ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Atherosclerosis; Matrix metalloproteinases; Polymorphism; Stromelysin

Indexed keywords

ADENOSINE; COLLAGENASE; ELASTIN; GELATINASE; MATRIX METALLOPROTEINASE; PROTEINASE; PROTEOGLYCAN; STROMELYSIN; TRANSCRIPTION FACTOR;

ALLELE; ANGIOGRAPHY; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL MIGRATION; CONNECTIVE TISSUE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; GENE OVEREXPRESSION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; TRANSCRIPTION REGULATION;

EID: 0031972894     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0940103     Document Type: Review

References (59)

1. Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995; 91: 2844-50.
2. Matrisian LM. Metalloproteinases and their inhibitors in matrix remodelling. Trends Genetics 1990; 6: 121-5.
3. Murphy G, Reynolds J. Extracellular matrix degradation. In: Royce PM, Steinman B, eds. Connective tissue and its heritable disorders. New York: Wiley-Liss Inc., 1993: 287-316.
4. Birkedal-Hansen H. Proteolytic remodelling of extracellular matrix. Curr Opin Cell Biol 1995; 7: 728-35.
5. Sato H, Takino T, Okada Y, et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature (London) 1994; 370: 61-5.
6. Alexander CM, Werb Z. Extracellular matrix degradation. In: Hay ED, ed. Cell biology of extracellular matrix. New York: Plenum Press, 1991: 255-302.
7. Birkedal-Hansen H, Moore WGI, Bodden MK, et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993; 4: 197-250.
8. Huhtala P, Chow LT, Tryggvason K. Structure of the human Type IV collagenase gene. J Biol Chem 1990; 265: 11077-82.
9. Huhtala P, Tuuttila A, Chow T, Lohi J, Keski-Oja J, Tryggvason K. Complete structure of the human gene for 92-kDa type IV collagenase. Divergent regulation of expression for the 92-and 72-kilodalton enzyme genes in HT-1080 cells. J Biol Chem 1991; 266: 16485-90.
10. Levy A, Zucman J, Delattre O, Mattel MG, Rio MC, Basset P. Assignment of the human stromelysin 3 (STMY3) gene to the q11.2 region of chromosome 22. Genomics 1992; 13: 881-3.
11. Formostone CJ, Byrd PJ, Ambrose HJ, et al. The order and orientation of a cluster of metalloproteinase genes, stromelysin 2, collagenase, and stromelysin, together with D11S385, on chromosome 11q22-q23. Genomics 1993; 16: 289-91.
12. Smith MW. A sequence-tagged site map of human chromosome 11. Genomics 1993; 17: 699-725.
13. Belaaouaj A, Shipley JM, Kobayashi DK, et al. Human macrophage metalloelastase. Genomic organization, chromosomal location, gene linkage, and tissue-specific expression. J Biol Chem 1995; 270: 14568-75.
14. Pendas AM, Matilla T, Estivill X, Lopez-Otin C. The human collagenase-3 (CLG3) gene is located on chromosome 11q22.3 clustered to other members of the matrix metalloproteinase gene family. Genomics 1995; 26: 615-8.
15. Knox JD, Boreham DR, Walker JA, et al. Mapping of the metalloproteinase gene matrilysin (MMP7) to human chromosome 11q21-q22. Cytogenet Cell Genet 1996; 72: 179-82.
16. Mignon C, Okada A, Mattei MG, Basset P. Assignment of the human membrane-type matrix metalloproteinase (MMP14) gene to 14q11-q12 by in situ hybridization. Genomics 1995; 28: 360-1.
17. Collier IE, Smith J, Kronberger A, et al. The structure of the human skin fibroblast collagenase gene. J Biol Chem 1988; 263: 10711-13.
18. Muller D, Quantin B, Gesnel MC, Milllon-Collard R, Abecassis J, Breathnach R. The collagenase gene family in humans consists of at least four members. Biochem J 1988; 253: 187-92.
19. Gaire M, Magbanua Z, McDonnell S, McNeil L, Lovett DH, Matrisian LM. Structure and expression of the human gene for the matrix metalloproteinase matrilysin. J Biol Chem 1994; 269: 2032-40.
20. Angel P, Baumann I, Stein B, Delius H, Rahmsdorf HJ, Herrlich P. 12-O-tetradecanoyl-phorbol-13-acetate (TPA) induction of the human collagenase gene is mediated by an inducible enhancer located in the 5′-flanking region. Mol Cell Biol 1987; 7: 2256-66.
21. Quinones S, Saus J, Otani Y, Harris Jr ED, Kurkinen M. Transcriptional regulation of human stromelysin. J Biol Chem 1989; 264: 8339-44.
22. Sirum K, Brinckerhoff CE. Cloning of the genes for human stromelysin and stromelysin-2: differential expression in rheumatoid synovial fibroblasts. 1989; 28: 8691-8.
23. Bou-Gharios G, Osman J, Black C, Olsen I. Excess matrix accumulation in scleroderma is caused partly by differential regulation of stromelysin and TIMP-1 synthesis. Clin Chim Acta 1994; 231: 69-78.
24. Henney AM, Wakeley PR, Davies MJ, et al. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sci USA 1991; 88: 8154-8.
25. Nikkari ST, O'Brien KD, Furguson M, et al. Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis. Circulation 1995; 92: 1393-8.
26. Galis ZS, Muszynski M, Sukhova GK, Simon-Morrissey E, Libby P. Enhanced expression of vascular matrix metalloproteinases induced in vitro by cytokines and in regions of human atherosclerotic lesions. Ann N Y Acad Sci 1995; 748: 501-7.
27. Galis ZS, Sukhova GK, Kranzhofer R, Clark S, Libby P. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinase. Proc Natl Acad Sci USA 1995; 92: 402-6.
28. Tyagi SC, Meyer L, Schmaltz RA, Reddy HK, Voelker DJ. Proteinases and restenosis in the human coronary artery: extracellular matrix production exceeds the expression of proteotytic activity. Atherosclerosis 1995; 116: 43-57.
29. Halpert I, Sires UI, Roby JD, et al. Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme. Proc Natl Acad Sci USA 1996; 93: 9748-53.
30. Li Z, Li L, Zielke HR, et al. Increased expression of 72-kd type IV collagenase (MMP-2) in human aortic atherosclerotic lesions. Am J Pathol 1996; 148: 121-8.
31. Nikkari ST, Geary RL, Hatsukami T, et al. Expression of collagen, interstitial collagenase, and tissue inhibitor of metalloproteinases-1 in restenosis after carotid endarterectomy. Am J Pathol 1996; 148: 777-83.
32. Zaltsman AB, Newby AC. Increased secretion of gelatinases A and B from the aortas of cholesterol fed rabbits: relationship to lesion severity. Atherosclerosis 1997; 130: 61-70.
33. Knox JB, Sukhova GK, Whittemore AD, Libby P. Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic diseases. Circulation 1997; 95: 205-12.
34. Stary HC, Blankenhom DH, Chandler B, et al. A definition of the intima of human arteries and of its atherosclerosis-prone regions. Arterioscler Thromb 1992; 12: 120-34.
35. Wight TN, Schonherr E, Jarvelainen H, Kinsella M, Evanko S, Lemire J. Regulation of proteoglycan synthesis by vascular cells. In: Woodford FP, Davignon J, Sniderman A, eds. Atherosclerosis. Amsterdam: Elsevier Science, 1995: 350-4.
36. Stary HC, Chandler AB, Glagov S, et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. Arterioscler Thromb 1994; 14: 840-56.
37. Camejo G, Hurt-Camejo E, Olsson U, Rosengren B, Bondjers G. Interaction of low density lipoprotein with proteoglycans: molecular basis and consequences. In: Woodford FP, Davignon J, Sniderman A, eds. Atherosclerosis. Amsterdam: Elsevier Science, 1995: 365-8.
38. Moore S, Alavi MZ. Vessel wall matrix: an overview. In: Woodford FP, Davignon J, Sniderman A, eds. Atherosclerosis. Amsterdam: Elsevier Science, 1995: 369-372.
39. Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson J. Molecular biology of the cell. New York: Garland Publishing Inc. 1994: 970-87.
40. Olsen BR. New insights into the function of collagens from genetic analysis. Curr Opin Cell Biol 1995; 7: 720-7.
41. Stary HC, Chandler AB, Dinsmore RE, et al. A definition of advanced types of atherosclerotic lesions and a histotogical classification of atherosclerosis. Arterioscler Thromb Vasc Biol 1995; 15: 15512-31.
42. Guyton JR, Klemp KF. Specific features of lipid deposits associated with arterial collagen and elastin. In: Woodford FP, Davignon J, Sniderman A, eds. Atherosclerosis. Amsterdam: Elsevier Science, 1995: 360-4.
43. Newby AC, Southgate KM, Davies M. Extracellular matrix degrading metalloproteinases in the pathogenesis of arteriosclerosis. Basic Res Cardiol 1994; 89(Suppl. 1): 59-70.
44. Clausell N, Molossi S, Rabinovitch M. Increased interleukin-1b and fibronectin expression are early features of the development of the postcardiac transplant coronary arteriopathy in piglets. Am J Pathol 1993; 142: 1772-86.
45. Clausell N, Molossi S, Sett S, Rabinovitch M. In vivo blockade of tumor necrosis factor-α in cholesterol rabbits after cardiac transplant inhibits acute coronary artery neointimal formation. Circulation 1994; 89: 2768-79.
46. Rabinovitch M. Elastase and cell extracellular matrix interactions in pathogenesis of intimal proliferation. In: Woodford FP, Davignon J, Sniderman A, eds. Atherosclerosis. Amsterdam: Elsevier Science, 1995: 338-49.
47. Bonnin CM, Sparrow MP, Taylor RR. Collagen synthesis and content in right ventricular hypertrophy in the dog. Am J Physiol 1981; 10: H703.
48. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature (London) 1993; 362: 801-9.
49. Pauly RR, Passaniti A, Bilato C, et al. Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation. Circ Res 1994; 75: 41-54.
50. Richardson PD, Davies MJ, Born GVR. Influence of plaque configuration and stress distribution of fissuring of coronary atherosclerotic plaques. Lancet 1989; ii: 941-4.
51. Fuster V, Badimon L, Badimon JJ, Ghesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (first of two parts). N Engl J Med 1992; 326: 242-50.
52. Lendon CL, Davies MJ, Born GVR, Richardson PD. Atherosclerotic plaque caps are locally weakened when macrophage density is increased. Atherosclerosis 1991; 87: 87-90.
53. Davies MJ, Richardson PD, Woolf N, Katz DR, Mann J. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content Br Heart J 1993; 69: 377-81
54. Humphries SE, Thomas A, Miller G, Hamster A, Green F. Interaction between genotype and environmental factors in the development of atherosclerotic-thrombotic disease: the effect of smoking on plasma levels of fibrinogen. In: Woodford FP, Davignon J, Sniderman A, eds. Atherosclerosis. Amsterdam: Elsevier Science, 1995: 628-33.
55. Green F, Humphries SE. Genetic determinants of arterial thrombosis. Bailliere's Clin Haematol 1994; 7: 675-92.
56. Ye S, Watts GF, Mandalia S, Humphries SE, Henney AM. Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis. Br Heart J 1995; 73: 209-15.
57. Ye S, Eriksson P, Hamsten A, Kurkinen M, Humphries SE, Henney AM. Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. J Biol Chem 1996; 271: 13055-60.
58. Sawicki G, Salas E, Murat J, Miszta-Lane H, Radomski MW. Release of gelatinase A during platelet activation mediates aggregation. Nature (London) 1997; 386: 616-9.
59. Mangan M, Miller K, Nayee P, et al. Processing of tumour necrosis factor-alpha precursor by metalloproteinases. Nature (London) 1994; 370: 555-7.